NO20043425L - Kondenserte bicykliske pyrimdin-derivater - Google Patents
Kondenserte bicykliske pyrimdin-derivaterInfo
- Publication number
- NO20043425L NO20043425L NO20043425A NO20043425A NO20043425L NO 20043425 L NO20043425 L NO 20043425L NO 20043425 A NO20043425 A NO 20043425A NO 20043425 A NO20043425 A NO 20043425A NO 20043425 L NO20043425 L NO 20043425L
- Authority
- NO
- Norway
- Prior art keywords
- pyrimdine
- derivatives
- ring
- condensed bicyclic
- receptor antagonist
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5365—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2002009373 | 2002-01-18 | ||
| PCT/JP2003/000263 WO2003062245A1 (fr) | 2002-01-18 | 2003-01-15 | Derives de pyrimidine fusionnes bicycliques |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20043425L true NO20043425L (no) | 2004-08-17 |
Family
ID=27605963
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20043425A NO20043425L (no) | 2002-01-18 | 2004-08-17 | Kondenserte bicykliske pyrimdin-derivater |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US6995153B2 (ja) |
| EP (1) | EP1473295B1 (ja) |
| JP (1) | JP4417720B2 (ja) |
| KR (1) | KR100887471B1 (ja) |
| CN (1) | CN1297559C (ja) |
| AT (1) | ATE427310T1 (ja) |
| AU (1) | AU2003201885B2 (ja) |
| BR (1) | BR0307156A (ja) |
| CA (1) | CA2472835A1 (ja) |
| DE (1) | DE60326933D1 (ja) |
| MX (1) | MXPA04006571A (ja) |
| NO (1) | NO20043425L (ja) |
| NZ (1) | NZ533540A (ja) |
| WO (1) | WO2003062245A1 (ja) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPWO2005019225A1 (ja) * | 2003-08-21 | 2007-11-01 | 杏林製薬株式会社 | Ｎｋ１受容体拮抗作用を有する化合物の製造方法及びその製造中間体 |
| CN1874766A (zh) * | 2003-10-27 | 2006-12-06 | 诺瓦提斯公司 | 神经激肽拮抗剂在尿失禁治疗中的用途 |
| WO2007132841A1 (ja) * | 2006-05-16 | 2007-11-22 | Takeda Pharmaceutical Company Limited | 縮合複素環化合物およびその用途 |
| US20090036425A1 (en) * | 2007-08-02 | 2009-02-05 | Pfizer Inc | Substituted bicyclolactam compounds |
| ES2672099T3 (es) | 2011-07-04 | 2018-06-12 | Irbm - Science Park S.P.A. | Antagonistas del receptor NK-1 para el tratamiento de la neovascularización corneal |
| FR2986232B1 (fr) * | 2012-01-26 | 2014-02-14 | Sanofi Sa | Derives heterocycliques bicycliques, leur preparation et leur application en therapeutique |
| CA3078945A1 (en) | 2017-10-09 | 2019-04-18 | Nuvation Bo Inc. | Heterocyclic compounds and uses thereof |
| US11299493B2 (en) | 2017-10-09 | 2022-04-12 | Nuvation Bio Inc. | Heterocyclic compounds and uses thereof |
| US20210015834A1 (en) | 2018-02-26 | 2021-01-21 | Ospedale San Raffaele S.R.L. | Nk-1 antagonists for use in the treatment of ocular pain |
| BR112021019703A2 (pt) | 2019-04-09 | 2021-12-14 | Nuvation Bio Inc | Compostos heterocíclicos e usos dos mesmos |
| EP3952878A4 (en) * | 2019-04-09 | 2023-01-04 | Nuvation Bio Inc. | HETEROCYCLIC COMPOUNDS AND USES THEREOF |
| EP3952879A4 (en) * | 2019-04-09 | 2023-01-04 | Nuvation Bio Inc. | HETEROCYCLIC COMPOUNDS AND USES THEREOF |
| US20230134843A1 (en) | 2020-03-11 | 2023-05-04 | Ospedale San Raffaele S.R.L. | Treatment of stem cell deficiency |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW263498B (ja) * | 1993-11-10 | 1995-11-21 | Takeda Pharm Industry Co Ltd | |
| ATE242243T1 (de) * | 1995-03-24 | 2003-06-15 | Takeda Chemical Industries Ltd | Zyklische verbindungen, ihre herstellung und ihre verwendung als tachykininrezeptorantagonisten |
| TW382017B (en) * | 1995-12-27 | 2000-02-11 | Janssen Pharmaceutica Nv | 1-(1,2-disubstituted piperidinyl)-4-(fused imidazole)-piperidine derivatives |
-
2003
- 2003-01-15 CA CA002472835A patent/CA2472835A1/en not_active Abandoned
- 2003-01-15 KR KR1020047011126A patent/KR100887471B1/ko not_active IP Right Cessation
- 2003-01-15 CN CNB03802425XA patent/CN1297559C/zh not_active Expired - Fee Related
- 2003-01-15 DE DE60326933T patent/DE60326933D1/de not_active Expired - Lifetime
- 2003-01-15 MX MXPA04006571A patent/MXPA04006571A/es active IP Right Grant
- 2003-01-15 AT AT03700567T patent/ATE427310T1/de not_active IP Right Cessation
- 2003-01-15 EP EP03700567A patent/EP1473295B1/en not_active Expired - Lifetime
- 2003-01-15 WO PCT/JP2003/000263 patent/WO2003062245A1/ja active Application Filing
- 2003-01-15 AU AU2003201885A patent/AU2003201885B2/en not_active Ceased
- 2003-01-15 BR BR0307156-1A patent/BR0307156A/pt not_active IP Right Cessation
- 2003-01-15 NZ NZ533540A patent/NZ533540A/en not_active IP Right Cessation
- 2003-01-15 US US10/501,551 patent/US6995153B2/en not_active Expired - Fee Related
- 2003-01-15 JP JP2003562122A patent/JP4417720B2/ja not_active Expired - Fee Related
-
2004
- 2004-08-17 NO NO20043425A patent/NO20043425L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| KR20040072732A (ko) | 2004-08-18 |
| JPWO2003062245A1 (ja) | 2005-05-19 |
| CN1620459A (zh) | 2005-05-25 |
| CN1297559C (zh) | 2007-01-31 |
| AU2003201885B2 (en) | 2007-08-30 |
| JP4417720B2 (ja) | 2010-02-17 |
| EP1473295B1 (en) | 2009-04-01 |
| US20050085469A1 (en) | 2005-04-21 |
| BR0307156A (pt) | 2004-12-07 |
| EP1473295A1 (en) | 2004-11-03 |
| NZ533540A (en) | 2006-04-28 |
| DE60326933D1 (de) | 2009-05-14 |
| US6995153B2 (en) | 2006-02-07 |
| MXPA04006571A (es) | 2004-10-04 |
| EP1473295A4 (en) | 2005-12-28 |
| WO2003062245A1 (fr) | 2003-07-31 |
| KR100887471B1 (ko) | 2009-03-10 |
| CA2472835A1 (en) | 2003-07-31 |
| ATE427310T1 (de) | 2009-04-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0414592A (pt) | antagonistas de receptores de trombina | |
| EA200300829A1 (ru) | Производные 1-арил- или 1-алкилсульфонилбензазола в качестве лигандов 5-гидрокситриптамина-6 | |
| DE602004009905D1 (de) | 6-substituierte nikotinamidderivate als opioidrezeptorantagonisten | |
| BRPI0000596B8 (pt) | composto piridona, processo de produção do composto, composição farmacêutica, e uso do dito composto | |
| ATE429427T1 (de) | Pyrimidinderivate als orexin-rezeptorantagonisten | |
| ATE377602T1 (de) | Morphinanderivate und ihre medizinische anwendung | |
| ATE427310T1 (de) | Kondensierte bicyclische pyrimidinderivate | |
| MXPA05013474A (es) | Derivados de quinolilamida como antagonistas de ccr-5. | |
| EA200400467A1 (ru) | Производные 3-азабицикло (3.1.0) гексана в качестве антагонистов опиоидного рецептора | |
| DK1129091T3 (da) | Antagonister for CRF-receptorer og fremgangsmåder med relation dertil | |
| PT1129096E (pt) | Antagonistas de receptor de crf e metodos de tratamento relacionados com os mesmos | |
| EA200501041A1 (ru) | Замещенные производные 1-пиперидин-4-ил-4-пирролидин-3-илпиперазина и их применение в качестве антагонистов нейрокининов | |
| EA200401455A1 (ru) | Производные бензоксазина в качестве модуляторов 5-htи их применение | |
| EA200300629A1 (ru) | Конденсированные производные пурина как антагонисты рецепторов аденозина a | |
| EA200600688A1 (ru) | Арилинденпиридины и арилинденпиримидины и их применение в качестве антагонистов аденозинового рецептора а2а | |
| CY1108837T1 (el) | ΝΕΑ ΠΑΡΑΓΩΓΑ ΑΜΙΝΟΠΥΡΙΔΙΝΗΣ ΩΣ ΑΝΤΑΓΩΝΙΣΤΕΣ mGluR5 | |
| ATE370140T1 (de) | Kondensierte bicyclische pyrimidinderivate | |
| EA200400822A1 (ru) | Производные 3,4-дигидро-1h-изохинолин-2-ила | |
| ATE407133T1 (de) | 2-imidazo-benzothiazole als adenosin-rezeptor liganden | |
| FR2801585B1 (fr) | Nouveaux antagonistes des recepteurs de l'ii-8 | |
| EA200401077A1 (ru) | 2-оксазоламины и их применение в качестве антагонистов рецептора 5-ht2b | |
| TR200001080T2 (tr) | 2 ile ikame edilmiş 1,2-Benisotiyazol türevleri ve bunların serrotonın antagonistleri | |
| ATE260918T1 (de) | Crf rezeptor-antagonisten und darauf bezogene methoden | |
| EP1489083A4 (en) | BICYCLIC PYRIMIDINE DERIVATIVE AND FUSIONED AS ANTAGONIST OF TACHYKININ RECEPTORS | |
| EP1457493A4 (en) | CONDENSED, BICYCLIC PYRIDINE DERIVATIVES AS TACHYKININ RECEPTOR ANTAGONISTS |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |